FdaApplication
NDA 022150
Identifiers
- fda_app_no: NDA022150
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2011-08-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FIRAZYR | ICATIBANT ACETATE | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | INJECTABLE;SUBCUTANEOUS |
1 product